| ID | Type | Location (GRCh37) | Location (GRCh38) | Length | GC content |
|---|---|---|---|---|---|
| hsa_ATP9B_0014000 | Exon-Exon | chr18:76953183-76974038 | chr18:79193183-79214038 | 234 nt | 0.4017 |
A study in mice demonstrated that circATP9B is highly expressed in early-stage hepatocellular carcinoma, bladder cancers, and breast cancer, and its decreased expression in myocardial tissues is associated with impaired cardiac function following acute myocardial infarction [Misir et al. DOI:10.1038/s41418-022-00948-7]. A study in humans demonstrated that the circATP9B was significantly downregulated in the peripheral blood mononuclear cells of heart failure patients exhibiting sacubitril/valsartan resistance compared to non-resistant patients, a finding validated by quantitative real-time PCR [Su et al. DOI:10.1016/j.ejphar.2023.175547].